How Use of Radioiodine Is Changing According to Risk Groups in Well Differentiated Thyroid Cancer?
Journal Title: Nuclear Medicine Seminars - Year 2021, Vol 7, Issue 1
Abstract
Many aspects of patient management in thyroid cancers including I-131 use are based on retrospective data or expert opinions and still debatable. With the increasing use of ultrasonography, demographics of thyroid cancers started to change starting from 1990s. Most of the newly diagnosed thyroid cancers are consisting of small intrathyroidal low risk tumors. The standard and intensive treatments and screening programs which failed to show any survival benefits has started arguments of over-treatment in thyroid cancers. Individualized treatment strategies based on changing demographic of thyroid cancer resulted in recommendation of less surgery, loosened follow-up protocols and less I-131 use as well. However, the need of re-interpretation of I-131 use is not a result of decreased effectiveness of radioiodine but rather increased numbers of surgically cured patients which would not benefit from I-131 therapy. Although new approaches will not change the use of I-131 in metastatic diseases, ablative and adjuvant use of I-131 needs to be re-considered within this perspective. These review aims to discuss changing role of I-131 in light of guidelines but a wider perspective to bring proposals which could facilitate our daily practice.
Authors and Affiliations
Seyfettin Ilgan
Keywords
Related Articles
- EP ID EP693435
- DOI 10.4274/nts.galenos.2021.0001
- Views 98
- Downloads 0
Essentials of Thyroid Hormone Treatment in Differentiated Thyroid Cancer
Levothyroxine is used for both hormone replacement and suppression of thyroid stimulating hormone (TSH) secretion from pituitary gland at supraphysiological doses in differentiated thyroid cancer (DTC). The impact of TSH...
Guideline for Dopaminergic Imaging in Parkinsonian Syndromes
The purpose of this guideline, which is prepared by the neuropsychiatry imaging task group of the Turkey Association of Nuclear Medicine, is to help nuclear medicine physicians in their practice of dopaminergic imaging i...
Radiation Safety Guide: General Definitions and Radiation Protection Rules in Nuclear Medicine Applications
Ionizing radiation which is widely used in the field of medicine and industry, and in scientific studies leaves some or all of its energy to the tissue as it passes through living tissue. It causes known possible harmful...
Options and Auxiliary Surgical Techniques in Residual or Recurrent Nodal Disease in Differentiated Thyroid Cancers
Despite their very good prognosis, residual or recurrent nodal disease can be seen in approximately 30% of patients in differentiated thyroid cancers (DTC). Nodal disease is most common in the neck and it can be treated...
How Use of Radioiodine Is Changing According to Risk Groups in Well Differentiated Thyroid Cancer?
Many aspects of patient management in thyroid cancers including I-131 use are based on retrospective data or expert opinions and still debatable. With the increasing use of ultrasonography, demographics of thyroid cancer...